CLO26-098: Factors Associated With Tumor Progression in HR+/HER2- Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: A Multi-Center Real-World Experience.
20260 citationsJournal Article
Field-Weighted Citation Impact: 0.00
CLO26-098: Factors Associated With Tumor Progression in HR+/HER2- Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: A Multi-Center Real-World Experience. | Researchclopedia